Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDTriSalus Life Sciences, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 2 | -$0.29 | -$0.08 | -$0.21 |
| Q2 2025 | 1 | -$0.17 | -$0.15 | -$0.16 |
| Q3 2025 | 1 | -$0.13 | -$0.11 | -$0.12 |
| Q4 2025 | 1 | -$0.08 | -$0.07 | -$0.08 |
| Q1 2026 | 0 | $0.00 | $0.00 | $0.00 |
| Q2 2026 | 0 | $0.00 | $0.00 | $0.00 |
| Q3 2026 | 0 | $0.00 | $0.00 | $0.00 |
| Q4 2026 | 0 | $0.00 | $0.00 | $0.00 |
| Q1 2027 | 0 | $0.00 | $0.00 | $0.00 |
| Q2 2027 | 0 | $0.00 | $0.00 | $0.00 |
| Q3 2027 | 0 | $0.00 | $0.00 | $0.00 |
| Q4 2027 | 0 | $0.00 | $0.00 | $0.00 |
TriSalus Life Sciences, Inc. Earnings Date And Information
TriSalus Life Sciences, Inc. last posted its earnings results on Thursday, November 14th, 2024. The company reported $-0.4 earnings per share for the quarter, missing analysts' consensus estimates of $-0.36 by $0.04. The company had revenue of 7.35 M for the quarter and had revenue of 18.51 M for the year. TriSalus Life Sciences, Inc. has generated $-7 earnings per share over the last year ($-6.73 diluted earnings per share) and currently has a price-to-earnings ratio of -2.24. TriSalus Life Sciences, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, April 7th, 2025 based on prior year's report dates.
TriSalus Life Sciences, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/14/2024 | Q3 2024 | -$0.36 | -$0.12 | 0.24 | $7.38 M | $7.35 M |
| 08/14/2024 | Q2 2024 | -$0.49 | -$0.21 | 0.28 | $6.88 M | $7.36 M |
| 03/30/2024 | Q1 2024 | -$0.57 | $6.46 M | |||
| 12/30/2023 | Q4 2023 | -$3.78 | $5.72 M | |||
| 09/29/2023 | Q3 2023 | -$0.10 | $5.19 M | |||
| 06/29/2023 | Q2 2023 | -$1.73 | $4.61 M | |||
| 03/30/2023 | Q1 2023 | -$0.51 | $2.98 M | |||
| 12/30/2022 | Q4 2022 | -$0.76 | $3.23 M | |||
| 09/29/2022 | Q3 2022 | -$0.26 | $3.92 M | |||
| 06/29/2022 | Q2 2022 | $0.08 | $2.88 M | |||
| 03/30/2022 | Q1 2022 | -$0.25 | $2.37 M | |||
| 03/02/2022 | Q4 2021 | $0.09 | $2.57 M | |||
| 12/13/2021 | Q3 2021 | $0.06 | $0 | |||
| 08/16/2021 | Q2 2021 | $0.01 | $0 | |||
| 06/28/2021 | Q1 2021 | -$0.01 | $0 | |||
| 12/13/2021 | Q4 2020 | -$0.00 | $0 |
TriSalus Life Sciences, Inc. Earnings: FAQ's
When is TriSalus Life Sciences, Inc.'s earnings date?
TriSalus Life Sciences, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, April 7th, 2025 based off last year's report dates.
How can I listen to TriSalus Life Sciences, Inc.'s earnings conference
call?
The conference call for TriSalus Life Sciences, Inc.'s latest earnings report can be listened to online.
How can I read TriSalus Life Sciences, Inc.'s conference call transcript?
The conference call transcript for TriSalus Life Sciences, Inc.'s latest earnings report can be read online.
How much revenue does TriSalus Life Sciences, Inc. generate each year?
TriSalus Life Sciences, Inc. (:TLSI) has a recorded annual revenue of $18.51 M.
How much profit does TriSalus Life Sciences, Inc. generate each year?
TriSalus Life Sciences, Inc. (:TLSI) has a recorded net income of $18.51 M. TriSalus Life Sciences, Inc. has generated $-6.73 earnings per share over the last four quarters.
What is TriSalus Life Sciences, Inc.'s price-to-earnings ratio?
TriSalus Life Sciences, Inc. (:TLSI) has a price-to-earnings ratio of -2.24 and price/earnings-to-growth ratio is 5.22.